SpaceX Investors Beware: IPOs Significantly Underperform the Market in Year 1

The article argues that Space Exploration Technologies' IPO enthusiasm may be premature, noting the stock traded at $166, 23% above its $150 IPO price, but IPOs often suffer meaningful first-year drawdowns. It highlights SpaceX's weak fundamentals, including a $4.3 billion net loss in Q1 2026 on $4.7 billion of revenue, and cites Elon Musk-related volatility as an additional risk. Overall, the piece recommends waiting rather than buying the IPO immediately.

Analysis

The near-term loser is not the IPO itself so much as the secondary supply overhang it creates across the crowded late-stage growth complex. When a high-profile listing is perceived as a liquidity event, it often pulls marginal capital away from adjacent names with similar narratives, which can compress multiples in the entire cohort for several weeks even if fundamentals are unchanged. That effect is most relevant for the fastest-moving momentum holders in software/AI and “story stock” baskets, where positioning is already extended and incremental buyers are price-sensitive.

The bigger second-order issue is that public-market scrutiny tends to reprice unprofitable growth faster than private-market marks did. If loss generation remains this large relative to revenue, the market will stop underwriting the business as an optionality asset and start valuing it as a capital intensity problem, which usually narrows the investor base to long-duration specialists and mechanically increases volatility. In that setup, any stumble in launch cadence, margin improvement, or funding access can trigger a de-rating well before the business model is truly broken.

The contrarian view is that the most obvious short thesis may be late. IPO momentum names often suffer their first meaningful drawdown only after the initial post-offering technicals clear and insider/lock-up dynamics begin to matter, so the better risk/reward may be to wait for a failed rally rather than short the first pop. Also, the behavioral risk tied to founder-led governance is already broadly recognized in the tape; what is less appreciated is that this can actually create periodic overshoots to the downside that are ripe for tactical mean reversion once sentiment gets washed out.

For the cited comps, the message is less about direct fundamentals and more about factor exposure: names with similar retail ownership and long-duration cash flow expectations can get sold together even if they are better businesses. That creates a cleaner relative-value opportunity than an outright index hedge, especially over the next 1-3 months while the market digests the listing and re-rates the whole speculative-growth bucket.

Key Decisions for Investors

• Avoid chasing the IPO into strength; wait for a 20-30% post-listing retracement or a failed breakout before considering any long exposure. Risk/reward is poor until the first wave of momentum buyers is cleared.
• Tactically short a basket of high-beta growth/retail-owned names into IPO strength for 2-6 weeks; use a basket rather than single-name exposure to reduce idiosyncratic squeeze risk.
• Pair trade: short the most sentiment-sensitive long-duration growth names against higher-quality AI beneficiaries with actual earnings leverage, using NVDA as the cleaner relative long versus speculative IPO-adjacent software. This should work if the market rotates from narrative to cash flow over the next quarter.
• For event-driven accounts, consider buying downside protection on the newly listed name once options liquidity is sufficient: 3-6 month puts or put spreads after implied volatility normalizes. Best payoff comes if operational updates disappoint within the first 1-2 earnings cycles.
• Monitor for lock-up expiration and secondary offering windows; those are the highest-probability catalysts for a sharper downside leg. If the stock is still trading above the IPO price by then, that is the point to lean into shorts rather than fade the initial excitement.